However, it remains unclear whether LCN2 could be a systemic biomarker in patients with IPF; further, the association of LCN2 with the pathogenesis of IPF and AE-IPF remains to be elucidated. The gene discussed is LCN2; the disease is idiopathic pulmonary fibrosis.